Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julie Joseph
Institution:
Health Canada
Observed institutions:
Health Canada,
University of Ottawa,
University of Würzburg,
Yale University,
Institute for Biological Sciences,
National Research Council Canada,
Drexel University
show all 7
ORCID:
0000-0002-6920-0364
Observed ORCID:
0000-0002-6920-0364
OpenAlex ID:
A5073736084
Identification of a T follicular helper cell subset that drives anaphylactic IgE
2019
·
Uthaman Gowthaman
, Jennifer S. Chen
, et al.
·
Science
·
477
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages
2014
·
Scott McComb
, Erin Cessford
, et al.
·
Proceedings of the National Academy of Sciences
·
190
PDF
Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization
2020
·
Biyan Zhang
, Elise Liu
, et al.
·
Science Immunology
·
83
IL-17 Silencing Does Not Protect Nonobese Diabetic Mice from Autoimmune Diabetes
2011
·
Julie Joseph
, Stefan Bittner
, et al.
·
The Journal of Immunology
·
66
PDF
Inhibition of ROS and upregulation of inflammatory cytokines by FoxO3a promotes survival against Salmonella typhimurium
2016
·
Julie Joseph
, Emmanuelle S. Ametepe
, et al.
·
Nature Communications
·
59
PDF
Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation
2016
·
Kelsey E Huus
, Julie Joseph
, et al.
·
The Journal of Immunology
·
43
Intrinsic Role of FoxO3a in the Development of CD8+ T Cell Memory
2013
·
Fanny Tzelepis
, Julie Joseph
, et al.
·
The Journal of Immunology
·
31
2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)
2023
·
Matt Szapacs
, Wenying Jian
, et al.
·
Bioanalysis
·
22
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Immunogenicity & Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)
2023
·
Luying Pan
, Johanna Mora
, et al.
·
Bioanalysis
·
17
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 – Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization
2023
·
Giane Sumner
, Steve Keller
, et al.
·
Bioanalysis
·
16
Can Soluble Immune Checkpoint Molecules on Exosomes Mediate Inflammation?
2021
·
Julie Joseph
, Benjamin Rahmani
, et al.
·
Journal of Neuroimmune Pharmacology
·
16
PDF
Metabolic fitness of IgA+ plasma cells in the gut requires DOCK8
2023
·
Biyan Zhang
, Shuting Chen
, et al.
·
Mucosal Immunology
·
13
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A – Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
2025
·
Omar Tounekti
, Sandra Prior
, et al.
·
Bioanalysis
·
11
Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics
2020
·
Matilde Hoffman
, DeGaulle I. Chigbu
, et al.
·
Springer eBooks
·
10
Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma
2022
·
Kiran K. Madugula
, Julie Joseph
, et al.
·
Haematologica
·
8
PDF
Foxo3a tempers excessive glutaminolysis in activated T cells to prevent fatal gut inflammation in the murine IL-10−/− model of colitis
2021
·
Stephanie Hajjar
, Nayanan Nathan
, et al.
·
Cell Death and Differentiation
·
8
PDF
Inhibitors of Tax1‐PDZ Interactions Block HTLV‐1 Viral Transmission by Changing EV Composition
2025
·
Jedidja Puttemans
, Yasmine Brammerloo
, et al.
·
Journal of Extracellular Vesicles
·
6
PDF
Retroviral b‐Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation
2023
·
Julie Joseph
, Thomas A. Premeaux
, et al.
·
Journal of Extracellular Biology
·
6
PDF
Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response
2024
·
Julie Joseph
, Thomas A. Premeaux
, et al.
·
Viruses
·
3
PDF
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines
2026
·
William P. Hausdorff
, Marco Cavaleri
, et al.
·
Vaccine
·
1
PDF
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
2023
·
Julie Joseph
, Grace Sandel
, et al.
·
Pathogens
·
1
PDF
Regulating immunity via exosomes by the retroviral bZip protein, HBZ, in HTLV-1-induced neuroinflammation
2024
·
Julie Joseph
, Pooja Jain
Myocyte enhancer factor-2C is critical for the maintenance of ATLL cells by regulating the activity of retroviral antisense promoter and bZIP
2023
·
Pooja Jain
, Kiran Madugula
, et al.
·
The Journal of Immunology
PDF
Extracellular immune checkpoint molecules released from HTLV-1-infected cells mount immune suppression in the context of neuroinflammation
2023
·
Julie Joseph
, Thomas Premeaux
, et al.
·
The Journal of Immunology
PDF
Role of exosomal BTLA/HVEM signaling in HTLV-1 associated diseases and associated T-cell dysfunction.
2022
·
Julie Joseph
, Abhishek Rao
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
27
Citation count:
1,087
H-index:
12
I10-index:
14
Year
Topic
Type
